Latin America Breast Biopsy Needle Market, By Needle Type (Fine-Needle Aspiration and Core Needle), Ergonomic (Sharp, Blunt, Quincke, Chiba, Franseen and Others), Procedure (Fine- Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy and Image-guided Biopsy), Usability (Disposable and Reusable), Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring and Recurrence Monitoring), End User (Hospitals, Diagnostic Centres, Biopsy Labs, Ambulatory Surgical Centres, Academic and Research Organizations and Others), Distribution Channel (Direct Tender and Retail Sales) – Industry Trends and Forecast to 2031.
Latin America Breast Biopsy Needle Market Analysis and Size
The breast biopsy needle market encompasses various biopsy techniques, including fine-needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy, and image-guided biopsy. Fine-needle aspiration biopsy involves extracting cells for cytology evaluation. Core needle biopsy retrieves tissue samples for histological examination. Vacuum-assisted biopsy employs suction for enhanced tissue retrieval, while image-guided biopsy utilizes imaging modalities for precise tissue targeting, collectively facilitating accurate diagnosis of breast abnormalities.
Data Bridge Market Research analyses that the Latin America breast biopsy needle market, which was USD 22.25 million in 2023, is expected to reach USD 40.28 million by 2031, at a CAGR of 7.7% during the forecast period 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2024-2031 |
|
Base Year |
2023 |
|
Historic Years |
2022 (Customizable to 2016-2021) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
(Fine-Needle Aspiration and Core Needle), Ergonomic (Sharp, Blunt, Quincke, Chiba, Franseen and Others), Procedure (Fine- Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy and Image-guided Biopsy), Usability (Disposable and Reusable), Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring and Recurrence Monitoring), End User (Hospitals, Diagnostic Centres, Biopsy Labs, Ambulatory Surgical Centres, Academic and Research Organizations and Others), Distribution Channel (Direct Tender and Retail Sales) |
|
Countries Covered |
U.S., Mexico, Brazil, Argentina, Columbia, Chile, Peru, Uruguay, Bolivia and Rest of Latin America. |
|
Market Players Covered |
Medax SRL (Italy), Cook (U.S.), BD (U.S.), AprioMed AB (Sweden), INRAD Inc. (U.S.), Hologic, Inc. (U.S.), Möller Medical GmbH (Germany), IZI Medical Products (U.S.), Merit Medical Systems, Inc. (U.S.), ADRIA MEDICAL (France), Devicor Medical Products Inc. (U.S.), Remington Medical Inc. (U.S.), PAJUNK GmbH (Germany) |
|
Market Opportunities |
|
Market Definition
A breast biopsy needle is a medical instrument used to extract tissue samples from the breast for diagnostic evaluation. It typically consists of a hollow, slender tube with a cutting edge or vacuum mechanism, allowing for precise targeting and retrieval of tissue for analysis, aiding in the detection and diagnosis of breast abnormalities.
Latin America Breast Biopsy Needle Market Dynamics
Drivers
- Technological Innovations Enhancing Biopsy Needle Efficacy
The technological advancements include the development of sharper, more precise needles and imaging technologies such as ultrasound and MRI-guided biopsies, enhancing diagnostic accuracy and patient comfort. By offering improved sampling quality and reducing procedure times, these innovations cater to the increasing demand for minimally invasive biopsy procedures. Consequently, the breast biopsy needle market is primarily driven by the continuous evolution of technologies aimed at enhancing biopsy needle efficacy and patient outcomes.
- Aging Population Contributing to Higher Biopsy Rates
As individuals age, the incidence of breast abnormalities and cancer increases, necessitating more frequent diagnostic procedures such as biopsies. This demographic trend translates into a greater demand for breast biopsy needles. Consequently, manufacturers are responding by developing advanced biopsy devices to meet this growing need. Thus, the aging population's impact on biopsy rates emerges as a key driver shaping the breast biopsy needle market.
Opportunities
- Rising Prevalence of Breast Cancer Cases Worldwide
With the rising prevalence of breast cancer cases, there is a growing demand for accurate diagnostic tools to facilitate early detection and treatment. Breast biopsy needles play a crucial role in obtaining tissue samples for histological examination, aiding in precise diagnosis and treatment planning. This increasing demand for biopsy needles underscores the opportunity for market growth and innovation in addressing breast cancer diagnosis and management.
- Integration of Artificial Intelligence for Biopsy Guidance
AI-driven systems can enhance biopsy accuracy by providing real-time guidance, improving targeting precision, and reducing procedural errors. By leveraging AI algorithms for image analysis and biopsy planning, healthcare providers can streamline biopsy procedures, leading to quicker diagnoses and improved patient outcomes. This integration not only enhances biopsy efficiency but also opens avenues for innovative AI-driven solutions, shaping the future of breast cancer diagnosis.
Restraints/Challenges
- Lack of Skilled Healthcare Professionals Performing Biopsies
The lack of skilled healthcare professionals reduces the frequency and quality of biopsies conducted, delaying or preventing timely detection and treatment of breast abnormalities. Additionally, the shortage of skilled personnel may lead to increased wait times for biopsy appointments, causing anxiety and frustration for patients. Consequently, the market faces challenges in expanding its reach and achieving optimal utilization of biopsy technologies in breast cancer diagnosis and management.
- High Costs Associated with Biopsy Procedures
The elevated expenses may deter individuals from undergoing biopsy examinations, leading to delayed diagnoses and treatment interventions. Moreover, healthcare providers may face financial constraints in procuring advanced biopsy needle technologies, hindering technological advancements and innovation within the market.
This Latin America breast biopsy needle market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Latin America breast biopsy needle market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In May 2023, Argon Medical Devices introduced the SuperCore Advantage Semi-Automatic Biopsy Instrument, a new addition to the biopsy needle market. This innovative device aims to improve biopsy procedures with enhanced efficiency and precision, potentially offering healthcare professionals advanced tools to enhance diagnostic accuracy and patient outcomes
- In April 2021, AprioMed extended its collaboration with Cenova, aiming to bolster its foothold in the South American market. This strategic alliance may enhance their presence and offerings in the breast biopsy needle market, potentially enabling AprioMed to capitalize on emerging opportunities and meet the region's healthcare needs more effectively
- In February 2021, Hologic Inc's acquisition of biotheranostics marked their entry into the expanding oncology market, including breast cancer. This strategic move enhances their network and capabilities in cancer diagnostics, potentially benefiting their offerings in the breast biopsy needle market through increased innovation and market presence
Latin America Breast Biopsy Needle Market Scope
The Latin America breast biopsy needle market is segmented on the basis of needle type, ergonomics, procedure, usability, application, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Needle Type
- Fine-Needle Aspiration
- Core Needle
Ergonomic
- Sharp
- Blunt
- Quincke
- Chiba
- Franseen
- Others
Procedure
- Fine- Needle Aspiration Biopsy
- Core Needle Biopsy
- Vacuum-Assisted Biopsy
- Image-Guided Biopsy
Usability
- Disposable
- Reusable
Application
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
End User
- Hospitals
- Diagnostic Centres
- Biopsy Labs
- Ambulatory Surgical Centres
- Academic and Research Organizations
- Others
Distribution Channel
- Direct Tender
- Retail Sales
Latin America Breast Biopsy Needle Market Regional Analysis/Insights
The Latin America breast biopsy needle market is analysed and market size insights and trends are provided by needle type, ergonomics, procedure, usability, application, end user and distribution channel as referenced above.
The countries covered in the Latin America breast biopsy needle market report are U.S., Mexico, Brazil, Argentina, Columbia, Chile, Peru, Uruguay, Bolivia and Rest of Latin America.
Brazil dominates the breast biopsy needle market is fueled by a rising incidence of breast cancer and increased public awareness of cancer screening. This creates a favorable environment for growth, as demand for biopsy needles for diagnostic purposes surges.
Mexico leads the breast biopsy needle market driven by a growing geriatric population, which is more susceptible to breast cancer. As the elderly demographic expands, demand for biopsy needles rises, fueling market dominance in the country.
Argentina's dominance in the breast biopsy needle market stems from the increasing utilization of artificial intelligence and machine learning to enhance diagnostic procedures. This technological integration fosters more accurate and efficient biopsy processes, driving market leadership in Argentina.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The Latin America breast biopsy needle market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Latin America breast biopsy needle market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Latin America breast biopsy needle market. The data is available for historic period 2016-2021.
Competitive Landscape and Latin America Breast Biopsy Needle Market Share Analysis
The Latin America breast biopsy needle market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Latin America breast biopsy needle market.
Some of the major players operating in the Latin America breast biopsy needle market are:
- Medax SRL (Italy)
- Cook (U.S.)
- BD (U.S.)
- AprioMed AB (Sweden)
- INRAD Inc. (U.S.)
- Hologic, Inc. (U.S.)
- Möller Medical GmbH (Germany)
- IZI Medical Products (U.S.)
- Merit Medical Systems, Inc. (U.S.)
- ADRIA MEDICAL (France)
- Devicor Medical Products Inc. (U.S.)
- Remington Medical Inc. (U.S.)
- PAJUNK GmbH (Germany)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
